Vitaceuticals Launches New Arthritis Relief Product
The MagZorb Joint Ease formula combines natural eggshell membrane with magnesium to assist joint health.
Updated on Oct. 20, 2026 in Arthritis
Live Poll
Do you trust dietary supplements to effectively manage your joint pain and stiffness?
Vitaceuticals has launched MagZorb Joint Ease across Australia, a new supplement combining natural eggshell membrane (NEM) with magnesium glycinate. The product enters the market as health experts revise recommendations for managing joint discomfort.
Why it matters
The launch arrives as clinical guidelines from the RACGP advise against the use of glucosamine and fish oil for osteoarthritis management. This move provides an alternative supplement option for the millions of Australians currently living with arthritis.
A human clinical trial found that 500 mg of NEM daily resulted in a 15.9% reduction in joint pain after 10 days of use. NEM is a natural ingredient containing collagen, chondroitin, and hyaluronic acid.
The players
Vitaceuticals
Vitaceuticals is a health and supplement company that manufactures and distributes nutritional products across the Australian market.
RACGP
The Royal Australian College of General Practitioners is an organization that sets clinical standards and guidelines for medical care in Australia.
The details
MagZorb Joint Ease is now available for purchase at major supermarkets, pharmacies, and via Amazon. The supplement integrates NEM, which has been studied in human clinical trials for over 15 years, with magnesium glycinate to support those experiencing osteoarthritis.
Timeline
2018: A placebo-controlled trial on post-menopausal women was conducted.
20 October 2026: The MagZorb Joint Ease product was officially launched.
2040: The number of Australians with arthritis is projected to reach 5.4 million.
The Big Picture
The launch of this product responds to the RACGP osteoarthritis clinical guidelines which currently advise against traditional supplement interventions. This marks a strategic shift to offer alternatives in a landscape where previous industry-standard treatments have fallen out of favour.
Consumers can now find the product on shelves at major supermarkets and pharmacies across the country. As osteoarthritis is 80% more common in women than men, this release offers a new over-the-counter option for those seeking to manage their daily joint health.
The takeaway
With 4.1 million Australians currently living with arthritis, the rise of evidence-based alternatives is a significant development for the ageing population. Patients should consult with their GP to discuss how new supplement options align with their specific joint health requirements.
Further reading
For more information on current management strategies, visit the Australia Arthritis section.
Source note: This article includes information reported by Vietnam Tribune.
Live Poll
Do you trust dietary supplements to effectively manage your joint pain and stiffness?
